Tidal Investments’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-25,600
Closed -$1.3M 2506
2025
Q4
$1.3M Buy
+25,600
New +$1.31M ﹤0.01% 1139
2025
Q1
Sell
-750
Closed -$24.4K 1960
2024
Q4
$24.4K Buy
+750
New +$81.1K ﹤0.01% 1813

Other funds holding NVO

Tidal Investments's NVO Position: Q2 2026 in Review

Tidal Investments reduced its Novo Nordisk (NVO) stake by 0.99% in Q2 2026, selling an estimated $32.4K and leaving 75,790 shares worth $3.63M. The position accounts for 0.01% of the portfolio, ranked #1085.

Tidal Investments first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $7.28M in Q4 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Tidal Investments held 75,790 shares of Novo Nordisk worth $3.63M as of Q2 2026.
  • Tidal Investments sold 755 Novo Nordisk shares in Q2 2026, an estimated $32.4K.
  • Novo Nordisk made up 0.01% of Tidal Investments's portfolio in Q2 2026, its #1085 holding.
  • Tidal Investments first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
  • Tidal Investments's Novo Nordisk position peaked at $7.28M in Q4 2024.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.